Lifeboat Foundation

“The Murakami Corporation has partnered with Parity Innovations, a startup that developed a holographic display technology, the Parity Mirror, which breaks up a projected image using a series of tiny mirrors and then refocuses them into a reconstituted image that appears to float in mid-air. What the Murakami Corporation brings to the table is its infrared sensors, which are able to detect the presence of fingers without them having to make physical contact. The result is a series of glowing buttons that don’t actually exist but can still be activated by touching them.”

Japanese smart toilets already provide a luxe experience, but this high-tech upgrade will take them to the next level.

Since its proprietary technology launched back in 2014, industrial 3D printer OEM Nano Dimension has built a name for itself in the world of additively manufactured electronics (AME).

With ongoing refinements to its flagship DragonFly LDM® 3D printer, the company is now doubling down on its 3D printing of high-performance electronic devices (Hi-PEDs™), an area in which it’s seen significant success in recent years. The Hi-PEDs™ targeted by the company often cannot be produced using traditional printed circuit board (PCB) manufacturing processes.

Yoav Stern, CEO of Nano Dimension, states, “We’re the 3D printing company for customers who need to stay on the cutting edge of electronics design. You’re creating the latest innovations in hardware development and electronic circuits. You need an additive manufacturing solution that allows you to go where no one has gone before in electronics design — and to get there faster and easier than ever before.”

Researchers from the Cluster of Excellence “CUI: Advanced Imaging of Matter” have achieved a breakthrough—creating a completely new type of plasma by combining state-of-the-art technologies using ultrashort laser pulses and ultracold atomic gases. They report on a novel electron cooling mechanism occurring in such plasmas in the journal Nature Communications.

An Israeli drug that has been successful in initial trials, could hold a key in blunting the COVID-19 pandemic. Thirty patients in serious condition participated in the trial and all recovered, most of them in less than a week. Sonya Cohen was one of them and she could one day be seen as a walking #miracle.

Follow Jerusalem Dateline and download the CBN News app to ensure you keep receiving news from a Christian Perspective. go.cbn.com/cbnapp.

#covidcure #Israel #Israeli #innovation #fightcovid #breakthrough.
Ichilov Hospital, Tel Aviv

These two high-quality, fully rigged sample characters represent the current state of the art for real-time digital humans and they’re yours to explore, modify, and use in your Unreal Engine 4.26.1 or later projects. They serve as a showcase of what’s achievable with MetaHuman Creator: an innovative new tool that will soon be available for you to create your own MetaHumans—in minutes.

Find out more at http://www.unrealengine.com/digital-humans.

A team of Australian researchers believe they have taken a significant step towards unlocking the regenerative power of the stem cells in our bodies.

2 things I like here. 1. Aubrey says not only does he think the first person to live to 1000 may be alive today but that they are already middle aged(Like me!). 2. In 15 years we might give a 70 year old treatment that will not make them 20 again, but perhaps it will make them 40. then by the time they hit 70 again the treatments available will be even better.

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501©(3) biomedical research charity that performs and funds laboratory research dedicated to combating aging. In addition, he is Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives 40–50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public. Topics Discussed: Brief overview of SENS
- Why try to end aging?
- How soon do you think we will end aging?
- What role does rejuvenation biotech play in the COVID-19 pandemic? How would regenerative medicine help us better cope with the pandemic?
- How are you implementing the techniques you research in your own life?
- Which breakthrough are you most proud of?Aubrey’s Links: LinkedIn: https://www.linkedin.com/in/aubrey-de-grey-24260b/
Personal Website: https://www.sens.org/
Company Website: https://www.mfoundation.org/
Twitter: https://twitter.com/aubreydegreyListen to the audio version at: https://www.buzzsprout.com/765170/7722976-dr-aubrey-de-grey-…e-agingYou can listen to the audio and read the transcript here: https://podcast.boomerliving.tv/dr-aubrey-de-grey-what-cause…-aging/You can listen to many other audio podcasts on our website and Apple Podcasts: https://podcast.boomerliving.tv/
https://podcasts.apple.com/us/podcast/boomer-living-senior-l…1455929808

It’s too early to call it a miracle cure, but if the conclusions from a recent Phase 1 trial for a new drug called EXO-C24 are backed up in subsequent trials, we might have the first true breakthrough therapy for COVID-19. That’s in addition to coronavirus vaccines, of course, which will help prevent severe COVID-19 cases and deaths, and even reduce the spread of the illness. But while vaccines can give the immune system a heads-up to the threat it might have to deal with — the real virus — they have a few limitations. First of all, they don’t work on infected people. Secondly, vaccine supply is still limited and vaccinations aren’t available to anybody who might want one. Then there’s the threat of coronavirus mutations that might reduce vaccines’ effect on the virus and extend the pandemic.

New research shows that patterns inspired by lobster shells can make 3D printed concrete stronger, to support more complex and creative architectural structures.

Digital manufacturing technologies like 3D concrete printing (3DCP) have immense potential to save time, effort and material in construction.

They also promise to push the boundaries of architectural innovation, yet technical challenges remain in making 3D printed concrete strong enough for use in more free-form structures.